Golden
Alkahest (company)

Alkahest (company)

A company developing anti-aging treatments using components derived from human blood.

Alkahest is a private biotechnology company based in San Carlos, California that was founded in 2014 by Tony Wyss-Coray. The company develops therapies derived from human blood and its components. It focuses on improving vitality and function into old age. Current developments include working on treatments for diseases of aging, with an emphasis on cognitive dysfunction and dementia. 



Alkahest's research has demonstrated that factors present in young plasma are able to improve brain deficits in pre-clinical models relevant to aging and Alzheimer's. The company is conducting clinical studies in patients with different types of dementia and other neurodegenerative diseases.

Products

Two main products in development, AKST/GRF6019 and AKST4290, are entering Phase 2 of clinical trials.

AKST/GRF6019

AKST/GRF6019 is a proprietary human plasma fraction that has shown evidence of enhancing neurogenesis and improve learning and memory in animals. It has several potential advantages over whole plasma. Clinical trials are being conducted for it's effects on Alzheimer's and Parkinson's Disease. The product is manufactured by Grifols, one of the world's largest producers of FDA approved blood and plasma derived products.

AKST4290

AKST4290 is a small molecule that is orally administered. Its purpose is to inhibit the interaction of CCL11, an inflammatory protein that has been implicated in a number of age related disease. Currently, Phase 2 clinical trials are being run with patients suffering from Wet AMD. It has also concluded Phase 1 clinical trials for a number of other neurodegenerative and inflammatory diseases related to aging.

Funding

Grant

On May 21, 2018 Alkahest received a grant worth an undisclosed amount from the Michael J. Fox Foundation. 

Timeline

People

Name
Role
LinkedIn

Bruce Morimoto

VP of Drug Development Operations



Elizabeth Jeffords

Chief Commercial & Strategy Officer



Jonas Hannestad

VP of Clinical Development



Joseph S. McCracken

VP of Business Development



Karoly Nikolich

CEO & Chairman of the Board of Directors



Micheal Byrnes

Chief Financial Officer



Steven Braithwaite

Chief Scientific Officer



Tammy Kent

VP of Human Resources and Operations



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References